These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Safety Analysis of Adverse Events of Ultrasound Contrast Agent Lumason/SonoVue in 49,100 Patients. Li Q; Yang K; Ji Y; Liu H; Fei X; Zhang Y; Li J; Luo Y Ultrasound Med Biol; 2023 Feb; 49(2):454-459. PubMed ID: 36357252 [TBL] [Abstract][Full Text] [Related]
5. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. Seitz K; Strobel D Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056 [TBL] [Abstract][Full Text] [Related]
6. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Bokor D; Chambers JB; Rees PJ; Mant TG; Luzzani F; Spinazzi A Invest Radiol; 2001 Feb; 36(2):104-9. PubMed ID: 11224758 [TBL] [Abstract][Full Text] [Related]
7. Use of Lumason Contrast Echocardiography in Post-myocardial Infarction Ventricular Septal Defect. Cinelli M; Karam B; Spagnola J; Assaad M; Salmane C; Hoyek W; Schwartz C Cureus; 2022 Jul; 14(7):e27128. PubMed ID: 36004020 [TBL] [Abstract][Full Text] [Related]
8. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387 [TBL] [Abstract][Full Text] [Related]
9. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason Arnouk S; Huynh Q; Saric M; Papadopoulos J J Pharm Pract; 2024 Apr; 37(2):509-512. PubMed ID: 36803045 [TBL] [Abstract][Full Text] [Related]
10. Anaphylaxis to Lumason Contrast Agent in Echocardiography after Immune Sensitization: A Case Report and Literature Review. Mikhail ES; Ghaly JB; Malik B; Ghatol AG J Community Hosp Intern Med Perspect; 2023; 13(4):74-78. PubMed ID: 37868230 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study. Hyvelin JM; Gaud E; Costa M; Helbert A; Bussat P; Bettinger T; Frinking P J Ultrasound Med; 2017 May; 36(5):941-953. PubMed ID: 28240842 [TBL] [Abstract][Full Text] [Related]
12. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. Senior R; Moreo A; Gaibazzi N; Agati L; Tiemann K; Shivalkar B; von Bardeleben S; Galiuto L; Lardoux H; Trocino G; Carrió I; Le Guludec D; Sambuceti G; Becher H; Colonna P; Ten Cate F; Bramucci E; Cohen A; Bezante G; Aggeli C; Kasprzak JD J Am Coll Cardiol; 2013 Oct; 62(15):1353-61. PubMed ID: 23770168 [TBL] [Abstract][Full Text] [Related]
13. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. Main ML; Hibberd MG; Ryan A; Lowe TJ; Miller P; Bhat G JACC Cardiovasc Imaging; 2014 Jan; 7(1):40-8. PubMed ID: 24290568 [TBL] [Abstract][Full Text] [Related]
14. Use of lumason/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses-a meta-analysis. Barr RG Abdom Radiol (NY); 2022 Jan; 47(1):272-287. PubMed ID: 34623494 [TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Barr RG; Huang P; Luo Y; Xie X; Zheng R; Yan K; Jing X; Luo Y; Xu H; Fei X; Lee JM Abdom Radiol (NY); 2020 Nov; 45(11):3779-3788. PubMed ID: 32424608 [TBL] [Abstract][Full Text] [Related]
18. SonoVue in transcranial Doppler investigations of the cerebral arteries. Kaps M; Legemate DA; Ries F; Ackerstaff RG; Markus H; Pezzoll C; Llull JB; Spinazzi A J Neuroimaging; 2001 Jul; 11(3):261-7. PubMed ID: 11462292 [TBL] [Abstract][Full Text] [Related]
19. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Keating GM Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233 [TBL] [Abstract][Full Text] [Related]